Profile Folgen

The billionaire banker whose finance firm has collapsed and who is now at the centre of a lobbying scandal involving ex-Prime Minister, David Cameron. Alexander "Lex" Greensill, grew up on his family’s sugar cane and melon farm in Queensland, Australia. After moving to the UK, he went into investment banking, founded a supply chain finance empire - complete with private jets - and, under David Cameron, secured a role in Britain’s Conservative-led Coalition government. After leaving office, the ex-PM became an adviser to the firm – Greensill Capital - which went bust last month, putting at risk 50,000 jobs worldwide. Mark Coles charts the rise and fall of the farmer’s son who, so the story goes, began his finance company to help small firms get paid more quickly by big businesses.Researchers: Matt Murphy and Stefania Okereke Producer: Sally Abrahams Editor: Richard Vadon

Emerald Fennell is the first British woman to be nominated for an Academy Award for Best Director. The film, that she also wrote - 'Promising Young Woman' - has been called a 'revenge-comedy', a movie for the #MeToo era. Fennell's rise has been meteoric - showrunner for the second series of 'Killing Eve', she's also well-known for her roles in front of the camera, including her portrayal of the Duchess of Cornwall, Camilla Parker Bowles, in 'The Crown'. Becky Milligan tells the story of a prolific and multi-talented young woman. Presenter: Becky Milligan Researchers: Matt Murphy and Stefania Okereke Studio manager: Rod Farquhar Programme co-ordinator: Janet Staples Producer: Linda Pressly Editor: Richard Vadon

AstraZeneca's CEO faces scrutiny as his company's vaccine, and its roll out, comes under fire. Mark Coles explores the life and career one of big pharma's biggest names. The oldest of four boys, Pascal Soriot grew up in a working class area of Paris. He took the helm at AZ in 2012 after years in top jobs across the world. One of his first challenges was to fight off a takeover from Pfizer. The AZ vaccine, currently not-for-profit, was hailed as a life saver for millions. But with accusations of confusing drug trial data, dishonest dealings with the EU and safety fears, has the AstraZeneca CEO lost his shine? Presenter: Mark Coles Researcher: Matt Murphy Studio manager: Graham Puddifoot Programme co-ordinator: Janet Staples Producer: Linda Pressly Editor: Rosamund Jones